Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08DWM
|
||||
Former ID |
DIB000597
|
||||
Drug Name |
Gp100:209-217(210M) peptide vaccine
|
||||
Synonyms |
Gp100 melanoma-associated antigen vaccine, NCI; Gp100:209-217(210M) peptide vaccine (melanoma); Gp100:209-217(210M) peptide vaccine (melanoma), NCI
|
||||
Drug Type |
Vaccine
|
||||
Indication | Melanoma [ICD9: 172; ICD10:C43] | Phase 2 | [521456] | ||
Company |
National Cancer Institute
|
||||
Target and Pathway | |||||
Target(s) | Melanocytes lineage-specific antigen GP100 | Target Info | [550405] | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.